Finzati - Logo
ILMN logo

Illumina, Inc.

ILMN • Medical - Diagnostics & Research
$218.22
▼ -3.44 (-1.55%)
Current price
EarningsLatest report: Jun 28, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$33.11B
Growth
21.7%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 19.6%Positive free cash flow · 6.01Consistent free cash flow · 5/5Healthy liquidity · 2.08
Financial data as of: Jun 28, 2026, 12:00 AM UTCLast earnings update: Jun 28, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$218.22
Change-1.55%
Shares Out154.00M
Market Cap$33.11B
Enterprise Value$34.39B
52W Range88.00 - 205.47
Beta1.47
P/E68.41
P/S7.37
P/B10.59
P/FCF35.68
EV/Sales7.65

Investment DNA

How strong this company looks for long-term investors

77
out of 100
Business Quality
Margins, moat, returns
86/100
Financial Strength
Debt, cash, stability
85/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
55/100
Why this score▼
Stable or improving margins · 19.6%Positive free cash flow · 6.01Consistent free cash flow · 5/5Healthy liquidity · 2.08

Analyst view

Analyst sentiment and price target

ILMN
Analyst sentiment
Based on 50 analyst votes · 2026-09-02
70/100
Bullish
Bullish
26
Hold
18
Bearish
6
Price Target
2026-07-31
Low
$135.00
Mean
$171.64
Median
$170.00
High
$226.00

Company Overview

IPO: 7/28/2000
Industry: Medical - Diagnostics & Research
P/B i: 10.59
Debt / Equity i: 0.94
Operating Margin: 19.92%
Net Margin: 19.59%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.94
Current Ratio: 2.08
Quick Ratio: 1.72
Status: Strong

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Sullivan Michael C
Transaction: 07/20/2026
OTHER
Change
0
Price
Not reported
Filing
07/29/2026
Type
OTHER
Ullem Scott B.
Transaction: 06/30/2026
BUY
Change
+167
Price
$149.19
Filing
07/02/2026
Type
BUY
Meister Keith A.
Transaction: 06/30/2026
BUY
Change
+142
Price
$149.19
Filing
07/02/2026
Type
BUY